International Patent: DUAL MODALITY RADIONUCLIDE-CONJUGATED ANTIBODY-DRUG CONJUGATES AND USE THEREOF

GENEVA, Sept. 18 -- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA filed a patent application (US2026/018136) for “DUAL MODALITY RADIONUCLIDE-CONJUGATED ANTIBODY-DRUG CONJUGATES AND USE THEREOF”. With publication no. WO/2026/188165, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....